• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL DELTAPAQ - CERECYTE MICROCOIL; NEUROVASCULAR EMBOLIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL DELTAPAQ - CERECYTE MICROCOIL; NEUROVASCULAR EMBOLIZATION DEVICE Back to Search Results
Catalog Number CDF10015430
Device Problem Positioning Failure (1158)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/28/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(6).It is anticipated that the device will be returned for analysis; however, the device has not yet been returned.Additional information will be submitted within 30 days of receipt.
 
Event Description
As reported by a healthcare professional, during the aneurysm embolization procedure, the deltapaq coil (cdf10015430/s10965) could not be detached.They used another one to complete the procedure.There was no report of patient injury.It was reported that the device would be returned for analysis.
 
Manufacturer Narrative
It was reported that the device would be returned for analysis; however, the device was not returned and after multiple attempts, no additional information was provided.The (b)(4) product was not returned for investigation.A review of manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection processes related to the reported complaint.The coil failure to detach could not be confirmed without product return for analysis.The root cause of the event could not be determined.There is no current safety signal identified related to the reported event based on review of complaint history for the device.Since there was no evidence to suggest the events was related to a manufacturing issues, no corrective actions will be taken at this time.
 
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).[conclusion]: the healthcare professional reported that during the coil embolization procedure of an aneurysm, the deltapaq 10 cerecyte coil 1.5mm x 4cm (cdf10015430 / s10965) could not be detached.They used another one to complete the procedure.There was no report of patient injury.Investigation summary: labeling on the inner pouch matches the product documented in the complaint.The introducer was not returned.The embolic coil was detached and not returned with the product.Two bends were observed in the device positioning unit (dpu) core wire approximately at 11 cm and 26 cm from the proximal end.The distal outer sheath has not softened indicating that the resistance heating (rh) coil has not heated.The resistance of the device was measured using multimeter 70042-04d.Resistance measured 51.9.The result is within the specification range of 48.5-56.0 per pic-cspec51460 rev.12.The device was connected to detachment control box dcb000005-00 (dcb) c38341 with a lab connecting cable and power was turned on.The system ready light turned on.Detachment cannot be tested because embolic coil was not returned.A review of manufacturing documentation associated with this lot (s10965) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no non-conformances related to device manufacture or inspection.All product rejected during manufacturing was identified as scrap and properly accounted for.Investigation conclusion: the complaint of failure to detach cannot be confirmed.As returned, the embolic coil is not attached to the dpu.The condition of the rh coil indicates that the detachment was mechanical.The resistance of the returned dpu is within the specification range, and the system ready light illuminates when the dpu is connected to a dcb.This evidence suggests that a detachment cycle was not initiated.The connecting cable and dcb were not returned.Without the return of these devices, the cause of the reported event cannot be identified.Device history lot
=
> a review of manufacturing documentation associated with this lot (s10965) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no non-conformances related to device manufacture or inspection.All product rejected during manufacturing was identified as scrap and properly accounted for.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective/preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTAPAQ - CERECYTE MICROCOIL
Type of Device
NEUROVASCULAR EMBOLIZATION DEVICE
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel
SZ 
MDR Report Key6886513
MDR Text Key89309795
Report Number2954740-2017-00276
Device Sequence Number1
Product Code HCG
UDI-Device Identifier00878528007036
UDI-Public(01)00878528007036(17)210531(10)S10965
Combination Product (y/n)N
PMA/PMN Number
K080437
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 08/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2021
Device Catalogue NumberCDF10015430
Device Lot NumberS10965
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/28/2018
Initial Date Manufacturer Received 08/30/2017
Initial Date FDA Received09/22/2017
Supplement Dates Manufacturer Received10/23/2017
06/28/2018
Supplement Dates FDA Received10/25/2017
07/18/2018
Patient Sequence Number1
-
-